Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Norbert Stefan, Ph.D., M.D.

Title
Institution
Department
Address
Profile Picture

Biography
University of Tübingen, Tübingen, GermanyMD1997Medicine
National Institutes of Health, Phoenix, AZ, USAResearch Fellow2003Diabetology
University of Tübingen, Tübingen, GermanySpecialization Internal Medicine2006Internal Medicine
University of Tübingen, Tübingen, GermanySenior Physician Internal Medicine (Endocrinology, Diabetology)2007Internal Medicine
University of Tübingen, Tübingen, GermanyPhD2007Diabetology
University of Tübingen, Tübingen, GermanySpecialization Endocrinology2019Internal Medicine
University of Tübingen, Tübingen, GermanyAssistant Professor2006Internal Medicine
University of Tübingen, Tübingen, GermanyAssociate Professor2007Internal Medicine
University of Tübingen, Tübingen, GermanyFull Professor2011Internal Medicine
2001
Silvia-King-Award, German Diabetes Association
2006
Nutrition Award, German Danone Institut für Gesundheit e.V.
2007
Rising Star Award, EASD
2007
Adiposity Award, German Society of Obesity
2008
Hannes Schoberth Award, German Society of Sports Medicine
2008 - 2011
Heisenberg Stipend
2009
Dr.-Werner-Fekl Award, German Society of Nutrition
2010 - 2014
Associate Editor of Diabetologia
2010
Ferdinand-Bertram-Award, German Diabetes Association
2010
Innovation Award, German Society for University Medicine
2011
Heisenberg-Professorship for clinical and experimental Diabetology
2012 - 2015
Executive Board Member German Diabetes Association
2014 - 2018
Advisory Board Member of Diabetologia
2015 - 2018
Editorial Board Member of Diabetes Care
2015 - ---
Editorial Board Member of The Lancet Diabetes & Endocrinology
2015
President of the 50th annual scientific meeting of the German Diabetes Association
2016
Prevention Award, German Society of Internal Medicine
2017
Werner-Creutzfeldt-Award, German Diabetes Association
2018
Visiting Professorship of Pediatrics, Harvard Medical School

Overview

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Lutz SZ, Hennige AM, Peter A, Kovarova M, Totsikas C, Machann J, Kröber SM, Sperl B, Schleicher E, Schick F, Heni M, Ullrich A, Häring HU, Stefan N. The Gly385(388)Arg Polymorphism of the FGFR4 Receptor Regulates Hepatic Lipogenesis Under Healthy Diet. J Clin Endocrinol Metab. 2019 Jun 01; 104(6):2041-2053. PMID: 30541128.
    Citations:    
  2. Jaghutriz BA, Wagner R, Heni M, Lehmann R, Machann J, Stefan N, Häring HU, Fritsche A. Metabolomic Characteristics of Fatty Pancreas. Exp Clin Endocrinol Diabetes. 2019 May 16. PMID: 31096268.
    Citations:    
  3. Schork A, Saynisch J, Vosseler A, Jaghutriz BA, Heyne N, Peter A, Häring HU, Stefan N, Fritsche A, Artunc F. Effect of SGLT2 inhibitors on body composition, fluid status and renin-angiotensin-aldosterone system in type 2 diabetes: a prospective study using bioimpedance spectroscopy. Cardiovasc Diabetol. 2019 04 05; 18(1):46. PMID: 30953516.
    Citations:    
  4. Kempe-Teufel D, Machicao F, Machann J, Böhm A, Schick F, Fritsche A, Stefan N, Hrabe de Angelis M, Häring HU, Staiger H. A Polygenic Risk Score of Lipolysis-Increasing Alleles Determines Visceral Fat Mass and Proinsulin Conversion. J Clin Endocrinol Metab. 2019 Apr 01; 104(4):1090-1098. PMID: 30649496.
    Citations:    Fields:    
  5. Lutz SZ, Wagner R, Fritsche L, Peter A, Rettig I, Willmann C, Fehlert E, Martus P, Todenhöfer T, Stefan N, Fritsche A, Häring HU, Heni M. Sex-Specific Associations of Testosterone With Metabolic Traits. Front Endocrinol (Lausanne). 2019; 10:90. PMID: 30930846.
    Citations:    
  6. Randrianarisoa E, Lehn-Stefan A, Hieronimus A, Rietig R, Fritsche A, Machann J, Balletshofer B, Häring HU, Stefan N, Rittig K. Visceral Adiposity Index as an Independent Marker of Subclinical Atherosclerosis in Individuals Prone to Diabetes Mellitus. J Atheroscler Thromb. 2019 Feb 19. PMID: 30787215.
    Citations:    
  7. Linder K, Willmann C, Kantartzis K, Machann J, Schick F, Graf M, Kümmerle S, Häring HU, Fritsche A, Stefan N, Wagner R. Dietary Niacin Intake Predicts the Decrease of Liver Fat Content During a Lifestyle Intervention. Sci Rep. 2019 Feb 04; 9(1):1303. PMID: 30718741.
    Citations:    
  8. Stefan N. [New aspects of nonalcoholic steatohepatitis]. Internist (Berl). 2019 02; 60(2):128-132. PMID: 30645665.
    Citations:    Fields:    
  9. Willmann C, Heni M, Linder K, Wagner R, Stefan N, Machann J, Schulze MB, Joost HG, Häring HU, Fritsche A. Potential effects of reduced red meat compared with increased fiber intake on glucose metabolism and liver fat content: a randomized and controlled dietary intervention study. Am J Clin Nutr. 2019 Feb 01; 109(2):288-296. PMID: 30721948.
    Citations:    
  10. Fritsche L, Sarief M, Wagner R, Stefan N, Lehmann R, Häring HU, Grallert H, Fritsche A, Lechner A. Genetic variation in TCF7L2 rs7903146 and history of GDM negatively and independently impact on diabetes-associated metabolic traits. Diabetes Res Clin Pract. 2018 Dec; 146:251-257. PMID: 30419301.
    Citations:    Fields:    Translation:Humans
  11. Ji Y, Yiorkas AM, Frau F, Mook-Kanamori D, Staiger H, Thomas EL, Atabaki-Pasdar N, Campbell A, Tyrrell J, Jones SE, Beaumont RN, Wood AR, Tuke MA, Ruth KS, Mahajan A, Murray A, Freathy RM, Weedon MN, Hattersley AT, Hayward C, Machann J, Häring HU, Franks P, de Mutsert R, Pearson E, Stefan N, Frayling TM, Allebrandt KV, Bell JD, Blakemore AI, Yaghootkar H. Genome-Wide and Abdominal MRI Data Provide Evidence That a Genetically Determined Favorable Adiposity Phenotype Is Characterized by Lower Ectopic Liver Fat and Lower Risk of Type 2 Diabetes, Heart Disease, and Hypertension. Diabetes. 2019 01; 68(1):207-219. PMID: 30352878.
    Citations:    Fields:    
  12. Stefan N, Häring HU, Cusi K. Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies. Lancet Diabetes Endocrinol. 2019 Apr; 7(4):313-324. PMID: 30174213.
    Citations:    Fields:    
  13. Eckel N, Li Y, Kuxhaus O, Stefan N, Hu FB, Schulze MB. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90?257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 2018 09; 6(9):714-724. PMID: 29859908.
    Citations:    Fields:    
  14. Lutz SZ, Falcenberg M, Machicao F, Peter A, Kächele M, Randrianarisoa E, Lehn-Stefan A, Wagner R, Machann J, Schick F, Heni M, Ullrich A, Fritsche A, Stefan N, Häring HU, Staiger H, Kantartzis K. Single Nucleotide Polymorphisms in the G-Protein Coupled Receptor Kinase 5 (GRK5) Gene are associated with Plasma LDL-Cholesterol Levels in Humans. Sci Rep. 2018 May 17; 8(1):7745. PMID: 29773828.
    Citations:    Fields:    
  15. Kantartzis K, Fritsche L, Bombrich M, Machann J, Schick F, Staiger H, Kunz I, Schoop R, Lehn-Stefan A, Heni M, Peter A, Fritsche A, Häring HU, Stefan N. Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial. Diabetes Obes Metab. 2018 07; 20(7):1793-1797. PMID: 29484808.
    Citations:    Fields:    Translation:Humans
  16. Kröger J, Meidtner K, Stefan N, Guevara M, Kerrison ND, Ardanaz E, Aune D, Boeing H, Dorronsoro M, Dow C, Fagherazzi G, Franks PW, Freisling H, Gunter MJ, Huerta JM, Kaaks R, Key TJ, Khaw KT, Krogh V, Kühn T, Mancini FR, Mattiello A, Nilsson PM, Olsen A, Overvad K, Palli D, Quirós JR, Rolandsson O, Sacerdote C, Sala N, Salamanca-Fernández E, Sluijs I, Spijkerman AMW, Tjonneland A, Tsilidis KK, Tumino R, van der Schouw YT, Forouhi NG, Sharp SJ, Langenberg C, Riboli E, Schulze MB, Wareham NJ. Circulating Fetuin-A and Risk of Type 2 Diabetes: A Mendelian Randomization Analysis. Diabetes. 2018 06; 67(6):1200-1205. PMID: 29523632.
    Citations:    Fields:    Translation:Humans
  17. Randrianarisoa E, Stefan N, Fritsche A, Hieronimus A, Balletshofer B, Machann J, Siegel-Axel D, Häring HU, Rittig K. Periaortic Adipose Tissue Compared With Peribrachial Adipose Tissue Mass as Markers and Possible Modulators of Cardiometabolic Risk. Angiology. 2018 11; 69(10):854-860. PMID: 29444588.
    Citations:    Fields:    Translation:Humans
  18. Nuñez-Durán E, Aghajan M, Amrutkar M, Sütt S, Cansby E, Booten SL, Watt A, Ståhlman M, Stefan N, Häring HU, Staiger H, Borén J, Marschall HU, Mahlapuu M. Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice. Hepatol Commun. 2018 01; 2(1):69-83. PMID: 29404514.
    Citations:    
  19. Peter A, Kovarova M, Staiger H, Machann J, Schick F, Königsrainer A, Königsrainer I, Schleicher E, Fritsche A, Häring HU, Stefan N. The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans. Am J Physiol Endocrinol Metab. 2018 03 01; 314(3):E266-E273. PMID: 29138227.
    Citations: 1     Fields:    
  20. Brendle C, Werner MK, Schmadl M, la Fougère C, Nikolaou K, Stefan N, Pfannenberg C. Correlation of Brown Adipose Tissue with Other Body Fat Compartments and Patient Characteristics: A Retrospective Analysis in a Large Patient Cohort Using PET/CT. Acad Radiol. 2018 Jan; 25(1):102-110. PMID: 29108812.
    Citations: 2     Fields:    Translation:Humans
  21. Stefan N, Häring HU, Schulze MB. Metabolically healthy obesity: the low-hanging fruit in obesity treatment? Lancet Diabetes Endocrinol. 2018 03; 6(3):249-258. PMID: 28919065.
    Citations: 6     Fields:    Translation:Humans
  22. Schmid V, Wagner R, Sailer C, Fritsche L, Kantartzis K, Peter A, Heni M, Häring HU, Stefan N, Fritsche A. Non-alcoholic fatty liver disease and impaired proinsulin conversion as newly identified predictors of the long-term non-response to a lifestyle intervention for diabetes prevention: results from the TULIP study. Diabetologia. 2017 12; 60(12):2341-2351. PMID: 28840257.
    Citations: 1     Fields:    Translation:Humans
  23. Gerst F, Wagner R, Kaiser G, Panse M, Heni M, Machann J, Bongers MN, Sartorius T, Sipos B, Fend F, Thiel C, Nadalin S, Königsrainer A, Stefan N, Fritsche A, Häring HU, Ullrich S, Siegel-Axel D. Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion. Diabetologia. 2017 Nov; 60(11):2240-2251. PMID: 28791439.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  24. Baumeier C, Schlüter L, Saussenthaler S, Laeger T, Rödiger M, Alaze SA, Fritsche L, Häring HU, Stefan N, Fritsche A, Schwenk RW, Schürmann A. Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease. Mol Metab. 2017 10; 6(10):1254-1263. PMID: 29031724.
    Citations:    
  25. Stefan N, Schick F, Häring HU. Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans. Cell Metab. 2017 Aug 01; 26(2):292-300. PMID: 28768170.
    Citations: 11     Fields:    Translation:Humans
  26. Böhm A, Wagner R, Machicao F, Holst JJ, Gallwitz B, Stefan N, Fritsche A, Häring HU, Staiger H. DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity. PLoS One. 2017; 12(7):e0181880. PMID: 28750074.
    Citations: 1     Fields:    Translation:HumansCells
  27. Wagner R, Fritsche L, Heni M, Fehlert E, Stefan N, Staiger H, Häring HU, Fritsche A. Erratum to: A novel insulin sensitivity index particularly suitable to measure insulin sensitivity during gestation. Acta Diabetol. 2017 07; 54(7):713-714. PMID: 28534066.
    Citations:    Fields:    
  28. Schulze MB, Stefan N. Genetic Predisposition to Abdominal Adiposity and Cardiometabolic Risk. JAMA. 2017 06 13; 317(22):2334. PMID: 28609526.
    Citations:    Fields:    Translation:Humans
  29. Fehlert E, Wagner R, Ketterer C, Böhm A, Machann J, Fritsche L, Machicao F, Schick F, Staiger H, Stefan N, Häring HU, Fritsche A, Heni M. Genetic determination of body fat distribution and the attributive influence on metabolism. Obesity (Silver Spring). 2017 07; 25(7):1277-1283. PMID: 28544651.
    Citations:    Fields:    Translation:Humans
  30. Machann J, Stefan N, Wagner R, Bongers M, Schleicher E, Fritsche A, Häring HU, Nikolaou K, Schick F. Intra- and interindividual variability of fatty acid unsaturation in six different human adipose tissue compartments assessed by 1 H-MRS in vivo at 3 T. NMR Biomed. 2017 Sep; 30(9). PMID: 28543814.
    Citations:    Fields:    Translation:Humans
  31. Ordelheide AM, Böhm A, Kempe-Teufel D, Wagner R, Machicao F, Heni M, Stefan N, Fritsche A, Häring HU, Staiger H. Common variation in the sodium/glucose cotransporter 2 gene SLC5A2 does neither affect fasting nor glucose-suppressed plasma glucagon concentrations. PLoS One. 2017; 12(5):e0177148. PMID: 28472182.
    Citations:    Fields:    Translation:Humans
  32. Heni M, Wagner R, Kullmann S, Gancheva S, Roden M, Peter A, Stefan N, Preissl H, Häring HU, Fritsche A. Hypothalamic and Striatal Insulin Action Suppresses Endogenous Glucose Production and May Stimulate Glucose Uptake During Hyperinsulinemia in Lean but Not in Overweight Men. Diabetes. 2017 07; 66(7):1797-1806. PMID: 28174292.
    Citations: 5     Fields:    Translation:HumansCells
  33. Wagner R, Hakaste LH, Ahlqvist E, Heni M, Machann J, Schick F, Van Obberghen E, Stefan N, Gallwitz B, Tuomi T, Häring HU, Groop L, Fritsche A. Nonsuppressed Glucagon After Glucose Challenge as a Potential Predictor for Glucose Tolerance. Diabetes. 2017 05; 66(5):1373-1379. PMID: 27986831.
    Citations: 1     Fields:    Translation:Humans
  34. Wagner R, Fritsche L, Heni M, Fehlert E, Stefan N, Staiger H, Häring HU, Fritsche A. A novel insulin sensitivity index particularly suitable to measure insulin sensitivity during gestation. Acta Diabetol. 2016 Dec; 53(6):1037-1044. PMID: 27771766.
    Citations: 4     Fields:    Translation:Humans
  35. Artunc F, Schleicher E, Weigert C, Fritsche A, Stefan N, Häring HU. The impact of insulin resistance on the kidney and vasculature. Nat Rev Nephrol. 2016 Dec; 12(12):721-737. PMID: 27748389.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  36. Lutz SZ, Peter A, Machicao F, Lamprinou A, Machann J, Schick F, Königsrainer I, Königsrainer A, Fritsche A, Staiger H, Häring HU, Stefan N, Kantartzis K. Genetic Variation in the 11ß-hydroxysteroid-dehydrogenase 1 Gene Determines NAFLD and Visceral Obesity. J Clin Endocrinol Metab. 2016 12; 101(12):4743-4751. PMID: 27715400.
    Citations: 2     Fields:    Translation:Humans
  37. Walford GA, Gustafsson S, Rybin D, Stancáková A, Chen H, Liu CT, Hong J, Jensen RA, Rice K, Morris AP, Mägi R, Tönjes A, Prokopenko I, Kleber ME, Delgado G, Silbernagel G, Jackson AU, Appel EV, Grarup N, Lewis JP, Montasser ME, Landenvall C, Staiger H, Luan J, Frayling TM, Weedon MN, Xie W, Morcillo S, Martínez-Larrad MT, Biggs ML, Chen YD, Corbaton-Anchuelo A, Færch K, Gómez-Zumaquero JM, Goodarzi MO, Kizer JR, Koistinen HA, Leong A, Lind L, Lindgren C, Machicao F, Manning AK, Martín-Núñez GM, Rojo-Martínez G, Rotter JI, Siscovick DS, Zmuda JM, Zhang Z, Serrano-Rios M, Smith U, Soriguer F, Hansen T, Jørgensen TJ, Linnenberg A, Pedersen O, Walker M, Langenberg C, Scott RA, Wareham NJ, Fritsche A, Häring HU, Stefan N, Groop L, O'Connell JR, Boehnke M, Bergman RN, Collins FS, Mohlke KL, Tuomilehto J, März W, Kovacs P, Stumvoll M, Psaty BM, Kuusisto J, Laakso M, Meigs JB, Dupuis J, Ingelsson E, Florez JC. Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci. Diabetes. 2016 10; 65(10):3200-11. PMID: 27416945.
    Citations: 6     Fields:    Translation:Humans
  38. Böhm A, Hoffmann C, Irmler M, Schneeweiss P, Schnauder G, Sailer C, Schmid V, Hudemann J, Machann J, Schick F, Beckers J, Hrabe de Angelis M, Staiger H, Fritsche A, Stefan N, Nieß AM, Häring HU, Weigert C. TGF-ß Contributes to Impaired Exercise Response by Suppression of Mitochondrial Key Regulators in Skeletal Muscle. Diabetes. 2016 10; 65(10):2849-61. PMID: 27358493.
    Citations: 7     Fields:    Translation:HumansCells
  39. Sailer C, Schmid V, Fritsche L, Gerter T, Machicao F, Niess A, Häring HU, Stefan N, Fritsche A, Heni M. FTO Genotype Interacts with Improvement in Aerobic Fitness on Body Weight Loss During Lifestyle Intervention. Obes Facts. 2016; 9(3):174-81. PMID: 27260224.
    Citations: 2     Fields:    Translation:Humans
  40. Randrianarisoa E, Lehn-Stefan A, Wang X, Hoene M, Peter A, Heinzmann SS, Zhao X, Königsrainer I, Königsrainer A, Balletshofer B, Machann J, Schick F, Fritsche A, Häring HU, Xu G, Lehmann R, Stefan N. Relationship of Serum Trimethylamine N-Oxide (TMAO) Levels with early Atherosclerosis in Humans. Sci Rep. 2016 05 27; 6:26745. PMID: 27228955.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  41. Stefan N, Fritsche A, Schick F, Häring HU. Phenotypes of prediabetes and stratification of cardiometabolic risk. Lancet Diabetes Endocrinol. 2016 09; 4(9):789-798. PMID: 27185609.
    Citations: 13     Fields:    Translation:Humans
  42. Ordelheide AM, Gommer N, Böhm A, Hermann C, Thielker I, Machicao F, Fritsche A, Stefan N, Häring HU, Staiger H. Granulocyte colony-stimulating factor (G-CSF): A saturated fatty acid-induced myokine with insulin-desensitizing properties in humans. Mol Metab. 2016 Apr; 5(4):305-316. PMID: 27069870.
    Citations: 3     Fields:    
  43. Stefan N, Häring HU, Hu FB, Schulze MB. Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications. Lancet Diabetes Endocrinol. 2016 05; 4(5):457-67. PMID: 26827112.
    Citations: 15     Fields:    Translation:HumansAnimals
  44. Machicao F, Peter A, Machann J, Königsrainer I, Böhm A, Lutz SZ, Heni M, Fritsche A, Schick F, Königsrainer A, Stefan N, Häring HU, Staiger H. Glucose-Raising Polymorphisms in the Human Clock Gene Cryptochrome 2 (CRY2) Affect Hepatic Lipid Content. PLoS One. 2016; 11(1):e0145563. PMID: 26726810.
    Citations: 1     Fields:    Translation:Humans
  45. Eckel N, Meidtner K, Kalle-Uhlmann T, Stefan N, Schulze MB. Metabolically healthy obesity and cardiovascular events: A systematic review and meta-analysis. Eur J Prev Cardiol. 2016 06; 23(9):956-66. PMID: 26701871.
    Citations: 17     Fields:    Translation:Humans
  46. Kächele M, Hennige AM, Machann J, Hieronimus A, Lamprinou A, Machicao F, Schick F, Fritsche A, Stefan N, Nürnberg B, Häring HU, Staiger H. Variation in the Phosphoinositide 3-Kinase Gamma Gene Affects Plasma HDL-Cholesterol without Modification of Metabolic or Inflammatory Markers. PLoS One. 2015; 10(12):e0144494. PMID: 26658747.
    Citations: 3     Fields:    Translation:HumansCells
  47. Stefan N, Staiger H, Wagner R, Machann J, Schick F, Häring HU, Fritsche A. A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes. Diabetologia. 2015 Dec; 58(12):2877-84. PMID: 26404062.
    Citations: 9     Fields:    Translation:Humans
  48. Forcisi S, Moritz F, Lucio M, Lehmann R, Stefan N, Schmitt-Kopplin P. Solutions for low and high accuracy mass spectrometric data matching: a data-driven annotation strategy in nontargeted metabolomics. Anal Chem. 2015 Sep 01; 87(17):8917-24. PMID: 26197019.
    Citations: 4     Fields:    Translation:Humans
  49. Jacobs S, Jäger S, Jansen E, Peter A, Stefan N, Boeing H, Schulze MB, Kröger J. Associations of Erythrocyte Fatty Acids in the De Novo Lipogenesis Pathway with Proxies of Liver Fat Accumulation in the EPIC-Potsdam Study. PLoS One. 2015; 10(5):e0127368. PMID: 25984792.
    Citations: 6     Fields:    Translation:HumansCells
  50. Berti L, Irmler M, Zdichavsky M, Meile T, Böhm A, Stefan N, Fritsche A, Beckers J, Königsrainer A, Häring HU, de Angelis MH, Staiger H. Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes. Mol Metab. 2015 Jul; 4(7):519-27. PMID: 26137439.
    Citations: 12     Fields:    
  51. Jäger S, Jacobs S, Kröger J, Stefan N, Fritsche A, Weikert C, Boeing H, Schulze MB. Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study. PLoS One. 2015; 10(4):e0124749. PMID: 25902304.
    Citations: 6     Fields:    Translation:Humans
  52. Eckel N, Mühlenbruch K, Meidtner K, Boeing H, Stefan N, Schulze MB. Characterization of metabolically unhealthy normal-weight individuals: Risk factors and their associations with type 2 diabetes. Metabolism. 2015 Aug; 64(8):862-71. PMID: 25861921.
    Citations: 9     Fields:    Translation:Humans
  53. Stefan N, Schick F, Häring HU. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. N Engl J Med. 2014 12 04; 371(23):2236-7. PMID: 25470709.
    Citations: 3     Fields:    Translation:Humans
  54. Stefan N, Peter A, Häring HU. Comment on Hedderson et al. Prepregnancy SHBG concentrations and risk for subsequently developing gestational diabetes mellitus. Diabetes Care 2014;37:1296-1303. Diabetes Care. 2014 Dec; 37(12):e278-9. PMID: 25414408.
    Citations: 1     Fields:    Translation:Humans
  55. Heni M, Wagner R, Kullmann S, Veit R, Mat Husin H, Linder K, Benkendorff C, Peter A, Stefan N, Häring HU, Preissl H, Fritsche A. Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men. Diabetes. 2014 Dec; 63(12):4083-8. PMID: 25028522.
    Citations: 29     Fields:    Translation:Humans
  56. Wagner R, Hieronimus A, Lamprinou A, Heni M, Hatziagelaki E, Ullrich S, Stefan N, Staiger H, Häring HU, Fritsche A. Peroxisome proliferator-activated receptor gamma (PPARG) modulates free fatty acid receptor 1 (FFAR1) dependent insulin secretion in humans. Mol Metab. 2014 Sep; 3(6):676-80. PMID: 25161890.
    Citations: 2     Fields:    
  57. Peter A, Kovarova M, Nadalin S, Cermak T, Königsrainer A, Machicao F, Stefan N, Häring HU, Schleicher E. PNPLA3 variant I148M is associated with altered hepatic lipid composition in humans. Diabetologia. 2014 Oct; 57(10):2103-7. PMID: 24972532.
    Citations: 9     Fields:    Translation:Humans
  58. Stefan N, Fritsche A, Häring HU. Mechanisms explaining the relationship between metabolically healthy obesity and cardiovascular risk. J Am Coll Cardiol. 2014 Jun 24; 63(24):2748-9. PMID: 24768870.
    Citations: 1     Fields:    Translation:Humans
  59. Stefan N, Artunc F, Heyne N, Machann J, Schleicher ED, Häring HU. Obesity and renal disease: not all fat is created equal and not all obesity is harmful to the kidneys. Nephrol Dial Transplant. 2016 05; 31(5):726-30. PMID: 24753460.
    Citations: 8     Fields:    Translation:HumansAnimals
  60. Böhm A, Halama A, Meile T, Zdichavsky M, Lehmann R, Weigert C, Fritsche A, Stefan N, Königsrainer A, Häring HU, de Angelis MH, Adamski J, Staiger H. Metabolic signatures of cultured human adipocytes from metabolically healthy versus unhealthy obese individuals. PLoS One. 2014; 9(4):e93148. PMID: 24695116.
    Citations: 9     Fields:    Translation:HumansCellsCTClinical Trials
  61. Linder K, Springer F, Machann J, Schick F, Fritsche A, Häring HU, Blumenstock G, Ranke MB, Stefan N, Binder G, Ehehalt S. Relationships of body composition and liver fat content with insulin resistance in obesity-matched adolescents and adults. Obesity (Silver Spring). 2014 May; 22(5):1325-31. PMID: 24375954.
    Citations: 6     Fields:    Translation:Humans
  62. Stefan N, Sun Q, Fritsche A, Machann J, Schick F, Gerst F, Jeppesen C, Joost HG, Hu FB, Boeing H, Ullrich S, Häring HU, Schulze MB. Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies. PLoS One. 2014; 9(3):e92238. PMID: 24643166.
    Citations: 17     Fields:    Translation:Humans
  63. Stefan N, Ramsauer M, Jordan P, Nowotny B, Kantartzis K, Machann J, Hwang JH, Nowotny P, Kahl S, Harreiter J, Hornemann S, Sanyal AJ, Stewart PM, Pfeiffer AF, Kautzky-Willer A, Roden M, Häring HU, Fürst-Recktenwald S. Inhibition of 11ß-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol. 2014 May; 2(5):406-16. PMID: 24795254.
    Citations: 17     Fields:    Translation:Humans
  64. Siegel-Axel DI, Ullrich S, Stefan N, Rittig K, Gerst F, Klingler C, Schmidt U, Schreiner B, Randrianarisoa E, Schaller HE, Stock UA, Weigert C, Königsrainer A, Häring HU. Fetuin-A influences vascular cell growth and production of proinflammatory and angiogenic proteins by human perivascular fat cells. Diabetologia. 2014 May; 57(5):1057-66. PMID: 24493202.
    Citations: 7     Fields:    Translation:HumansCells
  65. Wagner R, Staiger H, Ullrich S, Stefan N, Fritsche A, Häring HU. Untangling the interplay of genetic and metabolic influences on beta-cell function: Examples of potential therapeutic implications involving TCF7L2 and FFAR1. Mol Metab. 2014 Jun; 3(3):261-7. PMID: 24749055.
    Citations: 4     Fields:    
  66. Stienstra R, Stefan N. Tipping the inflammatory balance: inflammasome activation distinguishes metabolically unhealthy from healthy obesity. Diabetologia. 2013 Nov; 56(11):2343-6. PMID: 23995473.
    Citations: 1     Fields:    Translation:HumansCells
  67. Stefan N, Häring HU, Hu FB, Schulze MB. Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013 Oct; 1(2):152-62. PMID: 24622321.
    Citations: 72     Fields:    Translation:Humans
  68. Wagner R, Thorand B, Osterhoff MA, Müller G, Böhm A, Meisinger C, Kowall B, Rathmann W, Kronenberg F, Staiger H, Stefan N, Roden M, Schwarz PE, Pfeiffer AF, Häring HU, Fritsche A. Family history of diabetes is associated with higher risk for prediabetes: a multicentre analysis from the German Center for Diabetes Research. Diabetologia. 2013 Oct; 56(10):2176-80. PMID: 23979484.
    Citations: 5     Fields:    Translation:Humans
  69. Ordelheide AM, Gerst F, Rothfuss O, Heni M, Haas C, Thielker I, Herzberg-Schäfer S, Böhm A, Machicao F, Ullrich S, Stefan N, Fritsche A, Häring HU, Staiger H. Nor-1, a novel incretin-responsive regulator of insulin genes and insulin secretion. Mol Metab. 2013; 2(3):243-55. PMID: 24044104.
    Citations: 4     Fields:    
  70. Ezzat S, Zheng L, Florez JC, Stefan N, Mayr T, Hliang MM, Jablonski K, Harden M, Stancáková A, Laakso M, Haring HU, Ullrich A, Asa SL. The cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk of diabetes. Cell Metab. 2013 Jun 04; 17(6):929-40. PMID: 23747250.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  71. Heni M, Wagner R, Ketterer C, Böhm A, Linder K, Machicao F, Machann J, Schick F, Hennige AM, Stefan N, Häring HU, Fritsche A, Staiger H. Genetic variation in NR1H4 encoding the bile acid receptor FXR determines fasting glucose and free fatty acid levels in humans. J Clin Endocrinol Metab. 2013 Jul; 98(7):E1224-9. PMID: 23640969.
    Citations: 4     Fields:    Translation:Humans
  72. Staiger H, Böhm A, Scheler M, Berti L, Machann J, Schick F, Machicao F, Fritsche A, Stefan N, Weigert C, Krook A, Häring HU, de Angelis MH. Common genetic variation in the human FNDC5 locus, encoding the novel muscle-derived 'browning' factor irisin, determines insulin sensitivity. PLoS One. 2013; 8(4):e61903. PMID: 23637927.
    Citations: 16     Fields:    Translation:HumansCells
  73. Stefan N, Häring HU. Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans. Nat Med. 2013 Apr; 19(4):394-5. PMID: 23558619.
    Citations: 26     Fields:    Translation:Humans
  74. Lehmann R, Franken H, Dammeier S, Rosenbaum L, Kantartzis K, Peter A, Zell A, Adam P, Li J, Xu G, Königsrainer A, Machann J, Schick F, Hrabé de Angelis M, Schwab M, Staiger H, Schleicher E, Gastaldelli A, Fritsche A, Häring HU, Stefan N. Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. Diabetes Care. 2013 Aug; 36(8):2331-8. PMID: 23514731.
    Citations: 15     Fields:    Translation:Humans
  75. Stefan N, Schick F, Häring HU. Measures of adiposity and fat distribution and risk of diabetes. JAMA. 2013 Jan 23; 309(4):339-40. PMID: 23340625.
    Citations: 1     Fields:    Translation:Humans
  76. Stefan N, Häring HU. The role of hepatokines in metabolism. Nat Rev Endocrinol. 2013 Mar; 9(3):144-52. PMID: 23337953.
    Citations: 64     Fields:    Translation:Humans
  77. Arregui M, Buijsse B, Stefan N, Corella D, Fisher E, di Giuseppe R, Coltell O, Knüppel S, Aleksandrova K, Joost HG, Boeing H, Weikert C. Heterogeneity of the Stearoyl-CoA desaturase-1 (SCD1) gene and metabolic risk factors in the EPIC-Potsdam study. PLoS One. 2012; 7(11):e48338. PMID: 23139775.
    Citations: 3     Fields:    Translation:HumansAnimals
  78. Sartorius T, Staiger H, Ketterer C, Heni M, Machicao F, Guilherme A, Grallert H, Schulze MB, Boeing H, Stefan N, Fritsche A, Czech MP, Häring HU. Association of common genetic variants in the MAP4K4 locus with prediabetic traits in humans. PLoS One. 2012; 7(10):e47647. PMID: 23094072.
    Citations: 7     Fields:    Translation:HumansCells
  79. Floegel A, Stefan N, Yu Z, Mühlenbruch K, Drogan D, Joost HG, Fritsche A, Häring HU, Hrabe de Angelis M, Peters A, Roden M, Prehn C, Wang-Sattler R, Illig T, Schulze MB, Adamski J, Boeing H, Pischon T. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2013 Feb; 62(2):639-48. PMID: 23043162.
    Citations: 154     Fields:    Translation:Humans
  80. Silbernagel G, Kovarova M, Cegan A, Machann J, Schick F, Lehmann R, Häring HU, Stefan N, Schleicher E, Fritsche A, Peter A. High hepatic SCD1 activity is associated with low liver fat content in healthy subjects under a lipogenic diet. J Clin Endocrinol Metab. 2012 Dec; 97(12):E2288-92. PMID: 23015656.
    Citations: 18     Fields:    Translation:HumansCellsCTClinical Trials
  81. Machann J, Stefan N, Schabel C, Schleicher E, Fritsche A, Würslin C, Häring HU, Claussen CD, Schick F. Fraction of unsaturated fatty acids in visceral adipose tissue (VAT) is lower in subjects with high total VAT volume - a combined 1 H MRS and volumetric MRI study in male subjects. NMR Biomed. 2013 Feb; 26(2):232-6. PMID: 22972698.
    Citations: 3     Fields:    Translation:HumansAnimals
  82. Linder K, Wagner R, Hatziagelaki E, Ketterer C, Heni M, Machicao F, Stefan N, Staiger H, Häring HU, Fritsche A. Allele summation of diabetes risk genes predicts impaired glucose tolerance in female and obese individuals. PLoS One. 2012; 7(6):e38224. PMID: 22768041.
    Citations: 8     Fields:    Translation:Humans
  83. Stefan N, Fritsche A, Häring HU. [Diabetes and cancer risk]. Dtsch Med Wochenschr. 2012 May; 137(19):1003-6. PMID: 22549258.
    Citations:    Fields:    Translation:HumansAnimals
  84. Böhm A, Ordelheide AM, Machann J, Heni M, Ketterer C, Machicao F, Schick F, Stefan N, Fritsche A, Häring HU, Staiger H. Common genetic variation in the SERPINF1 locus determines overall adiposity, obesity-related insulin resistance, and circulating leptin levels. PLoS One. 2012; 7(3):e34035. PMID: 22457810.
    Citations: 7     Fields:    Translation:Humans
  85. Kantartzis K, Stefan N. Cardiovascular disease in patients with non-alcoholic fatty liver disease. Ann Gastroenterol. 2012; 25(3):276-277. PMID: 24713805.
    Citations: 2     
  86. Silbernagel G, Lütjohann D, Machann J, Meichsner S, Kantartzis K, Schick F, Häring HU, Stefan N, Fritsche A. Cholesterol synthesis is associated with hepatic lipid content and dependent on fructose/glucose intake in healthy humans. Exp Diabetes Res. 2012; 2012:361863. PMID: 22203835.
    Citations: 5     Fields:    Translation:Humans
  87. Schulze MB, Stefan N. The body adiposity index and the sexual dimorphism in body fat. Obesity (Silver Spring). 2011 Sep; 19(9):1729. PMID: 21874027.
    Citations: 9     Fields:    Translation:Humans
  88. Wagner R, Dudziak K, Herzberg-Schäfer SA, Machicao F, Stefan N, Staiger H, Häring HU, Fritsche A. Glucose-raising genetic variants in MADD and ADCY5 impair conversion of proinsulin to insulin. PLoS One. 2011; 6(8):e23639. PMID: 21887289.
    Citations: 9     Fields:    Translation:Humans
  89. Dudziak K, Machann J, Schick F, Claussen CD, Wehrmann M, Häring HU, Fritsche A, Stefan N, Müssig K. [Increased liver enzymes and metabolic risk - case 7/2011]. Dtsch Med Wochenschr. 2011 Jul; 136(28-29):1476. PMID: 21811970.
    Citations:    Fields:    Translation:Humans
  90. Stefan N, Häring HU. The metabolically benign and malignant fatty liver. Diabetes. 2011 Aug; 60(8):2011-7. PMID: 21788578.
    Citations: 46     Fields:    Translation:HumansAnimals
  91. Stefan N, Kantartzis K, Machann J, Schick F, Häring HU. Global trends in body-mass index. Lancet. 2011 Jun 04; 377(9781):1917; author reply 1917-8. PMID: 21641474.
    Citations: 1     Fields:    Translation:Humans
  92. Totsikas C, Röhm J, Kantartzis K, Thamer C, Rittig K, Machann J, Schick F, Hansel J, Niess A, Fritsche A, Häring HU, Stefan N. Cardiorespiratory fitness determines the reduction in blood pressure and insulin resistance during lifestyle intervention. J Hypertens. 2011 Jun; 29(6):1220-7. PMID: 21505353.
    Citations: 7     Fields:    Translation:Humans
  93. Ordelheide AM, Heni M, Thamer C, Machicao F, Fritsche A, Stefan N, Häring HU, Staiger H. In vitro responsiveness of human muscle cell peroxisome proliferator-activated receptor d reflects donors' insulin sensitivity in vivo. Eur J Clin Invest. 2011 Dec; 41(12):1323-9. PMID: 21615395.
    Citations: 1     Fields:    Translation:HumansCells
  94. Peter A, Stefan N, Cegan A, Walenta M, Wagner S, Königsrainer A, Königsrainer I, Machicao F, Schick F, Häring HU, Schleicher E. Hepatic glucokinase expression is associated with lipogenesis and fatty liver in humans. J Clin Endocrinol Metab. 2011 Jul; 96(7):E1126-30. PMID: 21490074.
    Citations: 29     Fields:    Translation:HumansCells
  95. Ketterer C, Müssig K, Heni M, Dudziak K, Randrianarisoa E, Wagner R, Machicao F, Stefan N, Holst JJ, Fritsche A, Häring HU, Staiger H. Genetic variation within the TRPM5 locus associates with prediabetic phenotypes in subjects at increased risk for type 2 diabetes. Metabolism. 2011 Sep; 60(9):1325-33. PMID: 21489577.
    Citations: 3     Fields:    Translation:Humans
  96. Stefan N, Häring HU. [Nonalcoholic steatohepatitis. Predictor and consequence of diabetes]. Internist (Berl). 2011 Apr; 52(4):389-94. PMID: 21373917.
    Citations:    Fields:    Translation:Humans
  97. Haap M, Machann J, von Friedeburg C, Schick F, Stefan N, Schwenzer NF, Fritsche A, Häring HU, Thamer C. Insulin sensitivity and liver fat: role of iron load. J Clin Endocrinol Metab. 2011 Jun; 96(6):E958-61. PMID: 21430023.
    Citations: 10     Fields:    Translation:Humans
  98. Silbernagel G, Machann J, Unmuth S, Schick F, Stefan N, Häring HU, Fritsche A. Effects of 4-week very-high-fructose/glucose diets on insulin sensitivity, visceral fat and intrahepatic lipids: an exploratory trial. Br J Nutr. 2011 Jul; 106(1):79-86. PMID: 21396140.
    Citations: 44     Fields:    Translation:Humans
  99. Herzberg-Schäfer SA, Staiger H, Heni M, Ketterer C, Guthoff M, Kantartzis K, Machicao F, Stefan N, Häring HU, Fritsche A. Evaluation of fasting state-/oral glucose tolerance test-derived measures of insulin release for the detection of genetically impaired ß-cell function. PLoS One. 2010 Dec 02; 5(12):e14194. PMID: 21152029.
    Citations: 16     Fields:    Translation:HumansCells
  100. Schwenzer NF, Machann J, Schraml C, Springer F, Ludescher B, Stefan N, Häring H, Fritsche A, Claussen CD, Schick F. Quantitative analysis of adipose tissue in single transverse slices for estimation of volumes of relevant fat tissue compartments: a study in a large cohort of subjects at risk for type 2 diabetes by MRI with comparison to anthropometric data. Invest Radiol. 2010 Dec; 45(12):788-94. PMID: 20829704.
    Citations: 14     Fields:    Translation:Humans
  101. Weyrich P, Staiger H, Stancáková A, Machicao F, Machann J, Schick F, Stefan N, Kuusisto J, Laakso M, Schäfer S, Fritsche A, Häring HU. The D299G/T399I Toll-like receptor 4 variant associates with body and liver fat: results from the TULIP and METSIM Studies. PLoS One. 2010 Nov 15; 5(11):e13980. PMID: 21125016.
    Citations: 6     Fields:    Translation:Humans
  102. Ketterer C, Müssig K, Machicao F, Stefan N, Fritsche A, Häring HU, Staiger H. Genetic variation within the NR1H2 gene encoding liver X receptor ß associates with insulin secretion in subjects at increased risk for type 2 diabetes. J Mol Med (Berl). 2011 Jan; 89(1):75-81. PMID: 21042792.
    Citations: 8     Fields:    Translation:HumansCells
  103. Peter A, Cegan A, Wagner S, Elcnerova M, Königsrainer A, Königsrainer I, Häring HU, Schleicher ED, Stefan N. Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans. Am J Physiol Endocrinol Metab. 2011 Feb; 300(2):E321-6. PMID: 21045174.
    Citations: 8     Fields:    Translation:Humans
  104. Heni M, Müssig K, Machicao F, Machann J, Schick F, Claussen CD, Stefan N, Fritsche A, Häring HU, Staiger H. Variants in the CD36 gene locus determine whole-body adiposity, but have no independent effect on insulin sensitivity. Obesity (Silver Spring). 2011 May; 19(5):1004-9. PMID: 20966915.
    Citations: 9     Fields:    Translation:Humans
  105. Stefan N, Staiger H, Häring HU. Dissociation between fatty liver and insulin resistance: the role of adipose triacylglycerol lipase. Diabetologia. 2011 Jan; 54(1):7-9. PMID: 20953581.
    Citations: 9     Fields:    Translation:HumansAnimals
  106. Peter A, Kantartzis K, Machann J, Schick F, Staiger H, Machicao F, Schleicher E, Fritsche A, Häring HU, Stefan N. Relationships of circulating sex hormone-binding globulin with metabolic traits in humans. Diabetes. 2010 Dec; 59(12):3167-73. PMID: 20841609.
    Citations: 40     Fields:    Translation:Humans
  107. Stefan N, Fritsche A, Häring HU. Letter by Stefan et al regarding article, "Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men". Circulation. 2010 Sep 14; 122(11):e456; author reply e457. PMID: 20837935.
    Citations: 2     Fields:    Translation:Humans
  108. Heni M, Ketterer C, Hart LM, Ranta F, van Haeften TW, Eekhoff EM, Dekker JM, Boomsma DI, Nijpels G, Kramer MH, Diamant M, Simonis-Bik AM, Heine RJ, de Geus EJ, Schäfer SA, Machicao F, Ullrich S, Thamer C, Stefan N, Staiger H, Häring HU, Fritsche A. The impact of genetic variation in the G6PC2 gene on insulin secretion depends on glycemia. J Clin Endocrinol Metab. 2010 Dec; 95(12):E479-84. PMID: 20826583.
    Citations: 9     Fields:    Translation:HumansCells
  109. Heni M, Ketterer C, Thamer C, Herzberg-Schäfer SA, Guthoff M, Stefan N, Machicao F, Staiger H, Fritsche A, Häring HU. Glycemia determines the effect of type 2 diabetes risk genes on insulin secretion. Diabetes. 2010 Dec; 59(12):3247-52. PMID: 20802253.
    Citations: 16     Fields:    Translation:Cells
  110. Machann J, Thamer C, Stefan N, Schwenzer NF, Kantartzis K, Häring HU, Claussen CD, Fritsche A, Schick F. Follow-up whole-body assessment of adipose tissue compartments during a lifestyle intervention in a large cohort at increased risk for type 2 diabetes. Radiology. 2010 Nov; 257(2):353-63. PMID: 20713612.
    Citations: 31     Fields:    Translation:Humans
  111. Thamer C, Machann J, Staiger H, Müssig K, Schwenzer N, Ludescher B, Machicao F, Claussen C, Fritsche A, Schick F, Stefan N, Häring HU. Interscapular fat is strongly associated with insulin resistance. J Clin Endocrinol Metab. 2010 Oct; 95(10):4736-42. PMID: 20660049.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  112. Heni M, Haupt A, Schäfer SA, Ketterer C, Thamer C, Machicao F, Stefan N, Staiger H, Häring HU, Fritsche A. Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion. BMC Med Genet. 2010 Jun 09; 11:86. PMID: 20534142.
    Citations: 18     Fields:    Translation:Humans
  113. Müssig K, Machicao F, Machann J, Schick F, Claussen CD, Stefan N, Fritsche A, Häring HU, Staiger H. No association between variation in the NR4A1 gene locus and metabolic traits in white subjects at increased risk for type 2 diabetes. BMC Med Genet. 2010 Jun 04; 11:84. PMID: 20525362.
    Citations: 2     Fields:    Translation:HumansCells
  114. Kantartzis K, Schick F, Häring HU, Stefan N. Environmental and genetic determinants of fatty liver in humans. Dig Dis. 2010; 28(1):169-78. PMID: 20460907.
    Citations: 9     Fields:    Translation:HumansCells
  115. Stefan N, Weikert C, Ix JH, Fritsche A, Häring HU. Association of lower plasma fetuin-a levels with peripheral arterial disease in type 2 diabetes: response to Eraso et al. Diabetes Care. 2010 Apr; 33(4):e55; author reply e56. PMID: 20351222.
    Citations: 3     Fields:    Translation:Humans
  116. Pfannenberg C, Werner MK, Ripkens S, Stef I, Deckert A, Schmadl M, Reimold M, Häring HU, Claussen CD, Stefan N. Impact of age on the relationships of brown adipose tissue with sex and adiposity in humans. Diabetes. 2010 Jul; 59(7):1789-93. PMID: 20357363.
    Citations: 77     Fields:    Translation:Humans
  117. Heni M, Machann J, Staiger H, Schwenzer NF, Peter A, Schick F, Claussen CD, Stefan N, Häring HU, Fritsche A. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev. 2010 Mar; 26(3):200-5. PMID: 20225188.
    Citations: 41     Fields:    Translation:HumansCells
  118. Stefan N, Schick F, Häring HU. Sex hormone-binding globulin and risk of type 2 diabetes. N Engl J Med. 2009 Dec 31; 361(27):2675-6; author reply 2677-8. PMID: 20042761.
    Citations: 11     Fields:    Translation:HumansCells
  119. Haupt A, Thamer C, Heni M, Ketterer C, Machann J, Schick F, Machicao F, Stefan N, Claussen CD, Häring HU, Fritsche A, Staiger H. Gene variants of TCF7L2 influence weight loss and body composition during lifestyle intervention in a population at risk for type 2 diabetes. Diabetes. 2010 Mar; 59(3):747-50. PMID: 20028944.
    Citations: 21     Fields:    Translation:Humans
  120. Haupt A, Thamer C, Heni M, Machicao F, Machann J, Schick F, Stefan N, Fritsche A, Häring HU, Staiger H. Novel obesity risk loci do not determine distribution of body fat depots: a whole-body MRI/MRS study. Obesity (Silver Spring). 2010 Jun; 18(6):1212-7. PMID: 19910938.
    Citations: 11     Fields:    Translation:Humans
  121. Stefan N, Kantartzis K, Celebi N, Staiger H, Machann J, Schick F, Cegan A, Elcnerova M, Schleicher E, Fritsche A, Häring HU. Circulating palmitoleate strongly and independently predicts insulin sensitivity in humans. Diabetes Care. 2010 Feb; 33(2):405-7. PMID: 19889804.
    Citations: 38     Fields:    Translation:HumansAnimals
  122. Peter A, Cegan A, Wagner S, Lehmann R, Stefan N, Königsrainer A, Königsrainer I, Häring HU, Schleicher E. Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios. Clin Chem. 2009 Dec; 55(12):2113-20. PMID: 19850634.
    Citations: 35     Fields:    Translation:HumansCells
  123. Tschritter O, Preissl H, Hennige AM, Sartorius T, Grichisch Y, Stefan N, Guthoff M, Düsing S, Machann J, Schleicher E, Cegan A, Birbaumer N, Fritsche A, Häring HU. The insulin effect on cerebrocortical theta activity is associated with serum concentrations of saturated nonesterified Fatty acids. J Clin Endocrinol Metab. 2009 Nov; 94(11):4600-7. PMID: 19820026.
    Citations: 12     Fields:    Translation:Humans
  124. Boesgaard TW, Gjesing AP, Grarup N, Rutanen J, Jansson PA, Hribal ML, Sesti G, Fritsche A, Stefan N, Staiger H, Häring H, Smith U, Laakso M, Pedersen O, Hansen T. Variant near ADAMTS9 known to associate with type 2 diabetes is related to insulin resistance in offspring of type 2 diabetes patients--EUGENE2 study. PLoS One. 2009 Sep 30; 4(9):e7236. PMID: 19789630.
    Citations: 18     Fields:    Translation:HumansCells
  125. Fisher E, Stefan N, Saar K, Drogan D, Schulze MB, Fritsche A, Joost HG, Häring HU, Hubner N, Boeing H, Weikert C. Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study. Circ Cardiovasc Genet. 2009 Dec; 2(6):607-13. PMID: 20031641.
    Citations: 25     Fields:    Translation:Humans
  126. Thamer C, Machicao F, Stefan N, Fritsche A, Häring HU. High baseline vitamin C levels do not prevent a positive outcome of a lifestyle intervention. Diabetes Care. 2009 Sep; 32(9):e112. PMID: 19717817.
    Citations: 2     Fields:    Translation:Humans
  127. Müssig K, Staiger H, Machicao F, Machann J, Schick F, Schäfer SA, Claussen CD, Holst JJ, Gallwitz B, Stefan N, Fritsche A, Häring HU. Preliminary report: genetic variation within the GPBAR1 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus. Metabolism. 2009 Dec; 58(12):1809-11. PMID: 19716570.
    Citations: 9     Fields:    Translation:Humans
  128. Weyrich P, Staiger H, Stancáková A, Schäfer SA, Kirchhoff K, Ullrich S, Ranta F, Gallwitz B, Stefan N, Machicao F, Kuusisto J, Laakso M, Fritsche A, Häring HU. Common polymorphisms within the NR4A3 locus, encoding the orphan nuclear receptor Nor-1, are associated with enhanced beta-cell function in non-diabetic subjects. BMC Med Genet. 2009 Aug 14; 10:77. PMID: 19682370.
    Citations: 8     Fields:    Translation:HumansCells
  129. Kantartzis K, Peter A, Machicao F, Machann J, Wagner S, Königsrainer I, Königsrainer A, Schick F, Fritsche A, Häring HU, Stefan N. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes. 2009 Nov; 58(11):2616-23. PMID: 19651814.
    Citations: 84     Fields:    Translation:Humans
  130. Stefan N, Pfannenberg C, Häring HU. The importance of brown adipose tissue. N Engl J Med. 2009 Jul 23; 361(4):416-7; author reply 418-21. PMID: 19630141.
    Citations: 10     Fields:    Translation:Humans
  131. Stefan N, Fritsche A, Häring HU. [Individualized prevention of type 2 diabetes]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2009 Jul; 52(7):677-82. PMID: 19626284.
    Citations: 1     Fields:    Translation:Humans
  132. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol. 2009 Sep; 51(3):433-45. PMID: 19604596.
    Citations: 121     Fields:    Translation:Humans
  133. Boettcher M, Machann J, Stefan N, Thamer C, Häring HU, Claussen CD, Fritsche A, Schick F. Intermuscular adipose tissue (IMAT): association with other adipose tissue compartments and insulin sensitivity. J Magn Reson Imaging. 2009 Jun; 29(6):1340-5. PMID: 19422021.
    Citations: 44     Fields:    Translation:Humans
  134. Peter A, Weigert C, Staiger H, Machicao F, Schick F, Machann J, Stefan N, Thamer C, Häring HU, Schleicher E. Individual stearoyl-coa desaturase 1 expression modulates endoplasmic reticulum stress and inflammation in human myotubes and is associated with skeletal muscle lipid storage and insulin sensitivity in vivo. Diabetes. 2009 Aug; 58(8):1757-65. PMID: 19478146.
    Citations: 50     Fields:    Translation:HumansCells
  135. Rittig K, Thamer C, Haupt A, Machann J, Peter A, Balletshofer B, Fritsche A, Haring HU, Stefan N. High plasma fetuin-A is associated with increased carotid intima-media thickness in a middle-aged population. Atherosclerosis. 2009 Dec; 207(2):341-2. PMID: 19615685.
    Citations: 15     Fields:    Translation:HumansCells
  136. Müssig K, Staiger H, Machicao F, Kirchhoff K, Guthoff M, Schäfer SA, Kantartzis K, Silbernagel G, Stefan N, Holst JJ, Gallwitz B, Häring HU, Fritsche A. Association of type 2 diabetes candidate polymorphisms in KCNQ1 with incretin and insulin secretion. Diabetes. 2009 Jul; 58(7):1715-20. PMID: 19366866.
    Citations: 33     Fields:    Translation:HumansCells
  137. Müssig K, Staiger H, Machicao F, Thamer C, Machann J, Schick F, Claussen CD, Stefan N, Fritsche A, Häring HU. RARRES2, encoding the novel adipokine chemerin, is a genetic determinant of disproportionate regional body fat distribution: a comparative magnetic resonance imaging study. Metabolism. 2009 Apr; 58(4):519-24. PMID: 19303973.
    Citations: 16     Fields:    Translation:Humans
  138. Haupt A, Guthoff M, Schäfer SA, Kirchhoff K, Machicao F, Gallwitz B, Staiger H, Stefan N, Fritsche A, Häring HU. The inhibitory effect of recent type 2 diabetes risk loci on insulin secretion is modulated by insulin sensitivity. J Clin Endocrinol Metab. 2009 May; 94(5):1775-80. PMID: 19258404.
    Citations: 6     Fields:    Translation:HumansCells
  139. Kantartzis K, Machicao F, Machann J, Schick F, Fritsche A, Häring HU, Stefan N. The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans. Clin Sci (Lond). 2009 Mar; 116(6):531-7. PMID: 18980578.
    Citations: 25     Fields:    Translation:Humans
  140. Müssig K, Staiger H, Machicao F, Stancáková A, Kuusisto J, Laakso M, Thamer C, Machann J, Schick F, Claussen CD, Stefan N, Fritsche A, Häring HU. Association of common genetic variation in the FOXO1 gene with beta-cell dysfunction, impaired glucose tolerance, and type 2 diabetes. J Clin Endocrinol Metab. 2009 Apr; 94(4):1353-60. PMID: 19141580.
    Citations: 9     Fields:    Translation:HumansCells
  141. Giel KE, Enck P, Zipfel S, Schrauth M, Bury A, Graf M, Kümmerle S, Guthoff M, Stefan N, Häring HU, Fritsche A. Psychological effects of prevention: do participants of a type 2 diabetes prevention program experience increased mental distress? Diabetes Metab Res Rev. 2009 Jan; 25(1):83-8. PMID: 19145589.
    Citations: 1     Fields:    Translation:Humans
  142. Staiger H, Machicao F, Schäfer SA, Kirchhoff K, Kantartzis K, Guthoff M, Silbernagel G, Stefan N, Häring HU, Fritsche A. Polymorphisms within the novel type 2 diabetes risk locus MTNR1B determine beta-cell function. PLoS One. 2008; 3(12):e3962. PMID: 19088850.
    Citations: 35     Fields:    Translation:HumansCells
  143. Staiger H, Haas C, Machann J, Werner R, Weisser M, Schick F, Machicao F, Stefan N, Fritsche A, Häring HU. Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes. 2009 Mar; 58(3):579-89. PMID: 19074989.
    Citations: 53     Fields:    Translation:HumansCells
  144. Schwenzer NF, Machann J, Haap MM, Martirosian P, Schraml C, Liebig G, Stefan N, Häring HU, Claussen CD, Fritsche A, Schick F. T2* relaxometry in liver, pancreas, and spleen in a healthy cohort of one hundred twenty-nine subjects-correlation with age, gender, and serum ferritin. Invest Radiol. 2008 Dec; 43(12):854-60. PMID: 19002057.
    Citations: 26     Fields:    Translation:Humans
  145. Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, Joost HG, Häring HU, Boeing H, Fritsche A. Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation. 2008 Dec 09; 118(24):2555-62. PMID: 19029462.
    Citations: 79     Fields:    Translation:Humans
  146. Stefan N, Häring HU, Schulze MB. Association of fetuin-A level and diabetes risk. JAMA. 2008 Nov 19; 300(19):2247; author reply 2247-8. PMID: 19017904.
    Citations: 7     Fields:    Translation:Humans
  147. Weyrich P, Machicao F, Reinhardt J, Machann J, Schick F, Tschritter O, Stefan N, Fritsche A, Häring HU. SIRT1 genetic variants associate with the metabolic response of Caucasians to a controlled lifestyle intervention--the TULIP Study. BMC Med Genet. 2008 Nov 12; 9:100. PMID: 19014491.
    Citations: 16     Fields:    Translation:Humans
  148. Friedrich B, Weyrich P, Stancáková A, Wang J, Kuusisto J, Laakso M, Sesti G, Succurro E, Smith U, Hansen T, Pedersen O, Machicao F, Schäfer S, Lang F, Risler T, Ullrich S, Stefan N, Fritsche A, Häring HU. Variance of the SGK1 gene is associated with insulin secretion in different European populations: results from the TUEF, EUGENE2, and METSIM studies. PLoS One. 2008; 3(11):e3506. PMID: 18985156.
    Citations: 5     Fields:    Translation:Humans
  149. Kantartzis K, Staiger H, Machann J, Schick F, Claussen CD, Machicao F, Fritsche A, Häring HU, Stefan N. Adiponectin oligomers and ectopic fat in liver and skeletal muscle in humans. Obesity (Silver Spring). 2009 Feb; 17(2):390-2. PMID: 19169222.
    Citations: 4     Fields:    Translation:Humans
  150. Fisher E, Schulze MB, Stefan N, Häring HU, Döring F, Joost HG, Al-Hasani H, Boeing H, Pischon T. Association of the FTO rs9939609 single nucleotide polymorphism with C-reactive protein levels. Obesity (Silver Spring). 2009 Feb; 17(2):330-4. PMID: 18948966.
    Citations: 8     Fields:    Translation:Humans
  151. Koska J, Stefan N, Votruba SB, Smith SR, Krakoff J, Bunt JC. Distribution of subcutaneous fat predicts insulin action in obesity in sex-specific manner. Obesity (Silver Spring). 2008 Sep; 16(9):2003-9. PMID: 18551127.
    Citations: 9     Fields:    Translation:Humans
  152. Stefan N, Kantartzis K, Häring HU. Causes and metabolic consequences of Fatty liver. Endocr Rev. 2008 Dec; 29(7):939-60. PMID: 18723451.
    Citations: 137     Fields:    Translation:Humans
  153. Staiger H, Machicao F, Kantartzis K, Schäfer SA, Kirchhoff K, Guthoff M, Silbernagel G, Stefan N, Fritsche A, Häring HU. Novel meta-analysis-derived type 2 diabetes risk loci do not determine prediabetic phenotypes. PLoS One. 2008 Aug 20; 3(8):e3019. PMID: 18714373.
    Citations: 19     Fields:    Translation:Humans
  154. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, Balletshofer B, Machicao F, Fritsche A, Häring HU. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008 Aug 11; 168(15):1609-16. PMID: 18695074.
    Citations: 268     Fields:    Translation:Humans
  155. Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, Häring HU, Schulze MB. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes. 2008 Oct; 57(10):2762-7. PMID: 18633113.
    Citations: 91     Fields:    Translation:Humans
  156. Haupt A, Thamer C, Machann J, Kirchhoff K, Stefan N, Tschritter O, Machicao F, Schick F, Häring HU, Fritsche A. Impact of variation in the FTO gene on whole body fat distribution, ectopic fat, and weight loss. Obesity (Silver Spring). 2008 Aug; 16(8):1969-72. PMID: 18535549.
    Citations: 36     Fields:    Translation:Humans
  157. Schwenzer NF, Machann J, Martirosian P, Stefan N, Schraml C, Fritsche A, Claussen CD, Schick F. Quantification of pancreatic lipomatosis and liver steatosis by MRI: comparison of in/opposed-phase and spectral-spatial excitation techniques. Invest Radiol. 2008 May; 43(5):330-7. PMID: 18424954.
    Citations: 32     Fields:    Translation:Humans
  158. Staiger H, Machicao F, Werner R, Guirguis A, Weisser M, Stefan N, Fritsche A, Häring HU. Genetic variation within the ANGPTL4 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus. Metabolism. 2008 May; 57(5):637-43. PMID: 18442626.
    Citations: 3     Fields:    Translation:Humans
  159. Machann J, Stefan N, Schick F. (1)H MR spectroscopy of skeletal muscle, liver and bone marrow. Eur J Radiol. 2008 Aug; 67(2):275-84. PMID: 18406092.
    Citations: 29     Fields:    Translation:Humans
  160. Hennige AM, Staiger H, Wicke C, Machicao F, Fritsche A, Häring HU, Stefan N. Fetuin-A induces cytokine expression and suppresses adiponectin production. PLoS One. 2008 Mar 12; 3(3):e1765. PMID: 18335040.
    Citations: 73     Fields:    Translation:HumansAnimalsCells
  161. Stefan N, Kantartzis K, Häring HU. Cardiorespiratory fitness, adiposity, and mortality. JAMA. 2008 Mar 05; 299(9):1013-4; author reply 1014. PMID: 18319407.
    Citations:    Fields:    Translation:Humans
  162. Stefan N, Peter A, Cegan A, Staiger H, Machann J, Schick F, Claussen CD, Fritsche A, Häring HU, Schleicher E. Low hepatic stearoyl-CoA desaturase 1 activity is associated with fatty liver and insulin resistance in obese humans. Diabetologia. 2008 Apr; 51(4):648-56. PMID: 18286258.
    Citations: 26     Fields:    Translation:Humans
  163. Stancáková A, Pihlajamäki J, Kuusisto J, Stefan N, Fritsche A, Häring H, Andreozzi F, Succurro E, Sesti G, Boesgaard TW, Hansen T, Pedersen O, Jansson PA, Hammarstedt A, Smith U, Laakso M. Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance. J Clin Endocrinol Metab. 2008 May; 93(5):1924-30. PMID: 18285412.
    Citations: 26     Fields:    Translation:Humans
  164. Thamer C, Machann J, Stefan N, Schäfer SA, Machicao F, Staiger H, Laakso M, Böttcher M, Claussen C, Schick F, Fritsche A, Haring HU. Variations in PPARD determine the change in body composition during lifestyle intervention: a whole-body magnetic resonance study. J Clin Endocrinol Metab. 2008 Apr; 93(4):1497-500. PMID: 18252792.
    Citations: 21     Fields:    Translation:Humans
  165. Koska J, Stefan N, Permana PA, Weyer C, Sonoda M, Bogardus C, Smith SR, Joanisse DR, Funahashi T, Krakoff J, Bunt JC. Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals. Am J Clin Nutr. 2008 Feb; 87(2):295-302. PMID: 18258617.
    Citations: 26     Fields:    Translation:HumansCells
  166. Rittig K, Peter A, Baltz KM, Tschritter O, Weigert C, Andreozzi F, Perticone F, Siegel-Axel DI, Stefan N, Fritsche A, Salih HR, Schleicher E, Machicao F, Sesti G, Häring HU, Balletshofer BM. The CCR2 promoter polymorphism T-960A, but not the serum MCP-1 level, is associated with endothelial function in prediabetic individuals. Atherosclerosis. 2008 Jun; 198(2):338-46. PMID: 18096169.
    Citations: 2     Fields:    Translation:HumansCells
  167. Staiger H, Stancáková A, Zilinskaite J, Vänttinen M, Hansen T, Marini MA, Hammarstedt A, Jansson PA, Sesti G, Smith U, Pedersen O, Laakso M, Stefan N, Fritsche A, Häring HU. A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study. Diabetes. 2008 Feb; 57(2):514-7. PMID: 18039816.
    Citations: 20     Fields:    Translation:Humans
  168. Kantartzis K, Rittig K, Cegan A, Machann J, Schick F, Balletshofer B, Fritsche A, Schleicher E, Häring HU, Stefan N. Fatty liver is independently associated with alterations in circulating HDL2 and HDL3 subfractions. Diabetes Care. 2008 Feb; 31(2):366-8. PMID: 18000185.
    Citations: 17     Fields:    Translation:Humans
  169. Staiger H, Machicao F, Stefan N, Tschritter O, Thamer C, Kantartzis K, Schäfer SA, Kirchhoff K, Fritsche A, Häring HU. Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function. PLoS One. 2007 Sep 05; 2(9):e832. PMID: 17786204.
    Citations: 47     Fields:    Translation:Humans
  170. Kirchhoff K, Kantartzis K, Machann J, Schick F, Thamer C, Machicao F, Fritsche A, Häring HU, Stefan N. Impact of different fat depots on insulin sensitivity: predominant role of liver fat. J Diabetes Sci Technol. 2007 Sep; 1(5):753-9. PMID: 19885144.
    Citations: 9     Fields:    
  171. Stefan N, Hennige AM, Staiger H, Schleicher E, Fritsche A, Häring HU. Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects: response to Broch et al. Diabetes Care. 2007 Aug; 30(8):e91; author reply e92. PMID: 17855276.
    Citations: 7     Fields:    Translation:Humans
  172. Schäfer S, Kantartzis K, Machann J, Venter C, Niess A, Schick F, Machicao F, Häring HU, Fritsche A, Stefan N. Lifestyle intervention in individuals with normal versus impaired glucose tolerance. Eur J Clin Invest. 2007 Jul; 37(7):535-43. PMID: 17576204.
    Citations: 32     Fields:    Translation:Humans
  173. Stefan N, Thamer C, Staiger H, Machicao F, Machann J, Schick F, Venter C, Niess A, Laakso M, Fritsche A, Häring HU. Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention. J Clin Endocrinol Metab. 2007 May; 92(5):1827-33. PMID: 17327385.
    Citations: 31     Fields:    Translation:HumansCells
  174. Thamer C, Machann J, Stefan N, Haap M, Schäfer S, Brenner S, Kantartzis K, Claussen C, Schick F, Haring H, Fritsche A. High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention. Obesity (Silver Spring). 2007 Feb; 15(2):531-8. PMID: 17299127.
    Citations: 31     Fields:    Translation:HumansCTClinical Trials
  175. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Schleicher E, Fritsche A, Häring HU. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care. 2007 May; 30(5):1173-8. PMID: 17259477.
    Citations: 56     Fields:    Translation:HumansCells
  176. Weyrich P, Stefan N, Häring HU, Laakso M, Fritsche A. Effect of genotype on success of lifestyle intervention in subjects at risk for type 2 diabetes. J Mol Med (Berl). 2007 Feb; 85(2):107-17. PMID: 17165091.
    Citations: 7     Fields:    Translation:Humans
  177. Kantartzis K, Fritsche A, Machicao F, Stumvoll M, Machann J, Schick F, Häring HU, Stefan N. Upstream transcription factor 1 gene polymorphisms are associated with high antilipolytic insulin sensitivity and show gene-gene interactions. J Mol Med (Berl). 2007 Jan; 85(1):55-61. PMID: 17016691.
    Citations: 3     Fields:    Translation:HumansCells
  178. Kantartzis K, Rittig K, Balletshofer B, Machann J, Schick F, Porubska K, Fritsche A, Häring HU, Stefan N. The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity. Clin Chem. 2006 Oct; 52(10):1934-42. PMID: 16916991.
    Citations: 17     Fields:    Translation:Humans
  179. Hennige AM, Stefan N, Kapp K, Lehmann R, Weigert C, Beck A, Moeschel K, Mushack J, Schleicher E, Häring HU. Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1. FASEB J. 2006 Jun; 20(8):1206-8. PMID: 16611834.
    Citations: 24     Fields:    Translation:HumansAnimalsCells
  180. Machann J, Thamer C, Schnoedt B, Stefan N, Haring HU, Claussen CD, Fritsche A, Schick F. Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med. 2006 Apr; 55(4):913-7. PMID: 16506186.
    Citations: 42     Fields:    Translation:Humans
  181. Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Kröber SM, Machicao F, Fritsche A, Häring HU. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care. 2006 Apr; 29(4):853-7. PMID: 16567827.
    Citations: 121     Fields:    Translation:Humans
  182. Kantartzis K, Fritsche A, Machicao F, Häring HU, Stefan N. The -8503 G/A polymorphism of the adiponectin receptor 1 gene is associated with insulin sensitivity dependent on adiposity. Diabetes Care. 2006 Feb; 29(2):464. PMID: 16443913.
    Citations: 4     Fields:    Translation:Humans
  183. Stefan N, Machann J, Schick F, Claussen CD, Thamer C, Fritsche A, Häring HU. New imaging techniques of fat, muscle and liver within the context of determining insulin sensitivity. Horm Res. 2005; 64 Suppl 3:38-44.